Frontlight ResearchEarly access
Head and neck cancer trials in United States
391 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleDe-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
- Where
- Orange
- Age
- 18 years and over
- People
- 111
- Run by
- University of California, Irvine
See details and how to joinNCT05600842 - Phase 2Taking peopleATATcH Alternating Treatment Plans for Advanced Cancer
- Where
- Elizabeth, Hamilton, Jersey City, Lakewood, Livingston, Long Branch, Newark, New Brunswick, Somerville, Toms River
- Age
- 18 years and over
- People
- 150
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT05358548 - No phaseTaking peopleProspective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
- Where
- Chapel Hill, North Charleston, Rochester
- Age
- 18 years and over
- People
- 220
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT04564989 - No phaseTaking peoplePromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors
- Where
- Miami
- Age
- 18 years to 80 years
- People
- 44
- Run by
- University of Miami
See details and how to joinNCT06124508 - No phaseTaking peopleVelopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
- Where
- Charlottesville
- Age
- 18 years and over
- People
- 20
- Run by
- Vanessa Torrecillas
See details and how to joinNCT07264036 - Phase 2Taking people5-Fluorouracil Response and Optimization STudy (The FROST Trial)
- Where
- St Louis
- Age
- 18 years and over
- People
- 46
- Run by
- Washington University School of Medicine
See details and how to joinNCT07419464 - Phase 2Taking peopleRisk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
- Where
- Charleston, Gainesville, Jacksonville
- Age
- 18 years and over
- People
- 250
- Run by
- University of Florida
See details and how to joinNCT05268614 - Phase 2Taking peopleA Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 121
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05491512 - Phase 2/3Taking peopleA Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers
- Where
- Chicago, Cleveland, Duarte, Miami
- Age
- 18 years to 100 years
- People
- 40
- Run by
- Privo Technologies
See details and how to joinNCT05893888 - Phase 2Taking peopleNeoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
- Where
- Baltimore
- Age
- 18 years and over
- People
- 75
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT07209189 - No phaseTaking peopleOropharynx (OPX) Biomarker Trial
- Where
- Rochester
- Age
- 18 years and over
- People
- 560
- Run by
- Mayo Clinic
See details and how to joinNCT06356272 - Phase 2Taking peopleInvert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy
- Where
- Dallas
- Age
- 18 years to 99 years
- People
- 80
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT06477692 - No phaseTaking peopleTreatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy
- Where
- Clinton, Washington D.C.
- Age
- 18 years and over
- People
- 30
- Run by
- Georgetown University
See details and how to joinNCT06902623 - Phase 2Taking peopleRadiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 120
- Run by
- Christopher Wilke
See details and how to joinNCT02128906 - Phase 1Taking peopleNeoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 22
- Run by
- Fox Chase Cancer Center
See details and how to joinNCT07455032 - No phaseTaking peopleNew MRI Biomarkers in Head and Neck Cancers
- Where
- New York
- Age
- 18 years and over
- People
- 200
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT03483337 - Phase 2Taking peopleA Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
- Where
- Dallas
- Age
- 18 years to 99 years
- People
- 120
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT05576974 - Phase 2Taking peopleA Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)
- Where
- Basking Ridge, Commack, East White Plains, Miami, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 30
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05307939 - No phaseTaking peopleProspective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
- Where
- New York
- Age
- 18 years and over
- People
- 1,800
- Run by
- The New York Proton Center
See details and how to joinNCT05313191 - Phase 1/2Taking peopleNisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)
- Where
- San Francisco
- Age
- 18 years and over
- People
- 40
- Run by
- University of California, San Francisco
See details and how to joinNCT06097468 - No phaseTaking peopleMolecular and Genomic Profiling of Head and Neck Tumors
- Where
- The Bronx
- People
- 1,000
- Run by
- Montefiore Medical Center
See details and how to joinNCT00200486 - Phase 3Taking peopleA Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Where
- Atlanta, Baltimore, Baton Rouge, Boston, Charleston, Chicago, Cincinnati, Columbus, Gilbert, Houston, Lake Success, Los Angeles, Milwaukee, New Haven, New York, Orlando, Philadelphia, Pittsburgh, Richmond, South Portland, St Louis, Tampa, The Bronx, Tucson, Washington D.C., Westwood
- Age
- 18 years and over
- People
- 410 worldwide
- Run by
- AVEO Pharmaceuticals, Inc.
See details and how to joinNCT06064877 · EU 2023-505606-42-00 - Phase 1/2Taking peopleA Study of DB-1310 in Advanced/Metastatic Solid Tumors
- Where
- Atlanta, Boston, Cincinnati, Coral Gables, Detroit, Fairfax, Florham Park, Margate, Nashville, Orlando, Plantation, Sacramento, Santa Monica, Sarasota, Tamarac
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05785741 - Phase 1Taking peopleThis is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Where
- Austin, TX 78758, Boston, San Antonio
- Age
- 18 years and over
- People
- 100
- Run by
- Zumutor Biologics Inc.
See details and how to joinNCT06451497 - Phase 2Taking peoplePhase 2 Trial of Adaptive Radiotherapy Boost for HNSCC
- Where
- Tampa
- Age
- 18 years and over
- People
- 35
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06137274